// App-Quantinova.ai

1487 : Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23

Researchers

Presenter

  • Dennis McGonagle

Principal Investigators

  • James Krueger

  • Kilian Eyerich

  • Carrie Greving

  • Kacey Sachen

  • Deepa Hammaker

  • Phuc Bao

  • Eilyn Lacy

  • M. Merle Elloso

  • Yevgeniya Orlovsky

  • Iain B McInnes

  • Anne Fourie

Medical Centers

  • The Rockefeller University, New York, NY

  • Technical University, Munich, Germany / Karolinska Institute, Stockholm, Sweden

  • University of Leeds, Leeds, United Kingdom

  • Janssen Research & Development, LLC, Spring House, PA/San Diego, Spring House, PA/San Diego, CA

  • Janssen Research and Development, LLC, Spring House, PA

  • Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  • Janssen Research & Development, LLC, Spring House, PA/San Diego, Spring House, PA/San Diego, CA

Locations

  • United States

  • Sweden

  • United Kingdom

Companies

  • JB Medical Ltd.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved